Chest Imaging, Breath, and Biomarkers in a Screening Trial

May 17, 2017 updated by: Moulay Meziane, MD, The Cleveland Clinic

A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Study Overview

Status

Completed

Conditions

Detailed Description

The fight against lung cancer is waged on three major fronts: prevention, detection and treatment. Our goal is to determine if chest x-rays,computer aided detection (CAD)and a CT scan can detect disease earlier when treatment is more effective. If we improve the detection of disease, we will see if screening reduces the incidence of symptomatic advanced lung cancer relative to no screening in people at high risk to develop lung cancer.

Study Type

Observational

Enrollment (Actual)

1424

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Primary care physicians or any other physician may refer potential candidates. Additionally, subjects may see marketing materials and contact the research team directly. There is no restriction to the area of residence of subjects.

Description

Inclusion Criteria:

  • ages 40-75 years
  • If ages 40-59, then one of the following criteria needs to be met:

    • Current or ex-smoker with >25 pack years and a family history of lung cancer(parent or sibling) OR
    • current or ex-smoker with > 25 pack years and COPD OR
    • current or ex-smoker with a > 35 pack year history
  • If ages 60-75, then one of the following additional criteria needs to be met:

    • Current or ex-smoker with >25 pack years and a family history of lung cancer (parent or sibling) OR
    • Current or ex-smoker with >25 pack years and COPD OR
    • Current or ex-smoker with a >30 pack year history
  • Subject is able to return to Cleveland Clinic for annual follow-up screening
  • Subject is willing to sign a medical release form

Exclusion Criteria:

  • Current health requires oxygen
  • Have had a chest x-ray or CT of the chest within the last 6 months
  • Previous pneumonectomy
  • Lobectomy of the lung within the last 5 years
  • Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer
  • A medical condition that would prevent treatment for lung cancer
  • Within the last 6 weeks, one of the following has occured:

    • A new cough or chronic cough that has gotten worse
    • Either new shortness of breath, or any worsening of shortness of breath
    • A cough producing blood
    • Constant chest pain
    • Respiratory infection, pneumonia, or cold
    • Unintentional and unexplained weight loss greater than 5% of total body weight

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
all enrolled subjects
Intervention is chest x-ray and CT scan. The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader. Subjects are asked to contribute breath and blood samples.
PA view, low dose CT scan
Other Names:
  • CAD
  • computer aided detection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The sensitivities of chest x-ray with CAD and chest CT
Time Frame: One year after scan
The false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.
One year after scan

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-specific mortality between screening with chest x-ray and CAD versus no screening
Time Frame: One year after scan
Mortality rate in screening x-ray vs CAD
One year after scan
All-cause mortality rate between screening with chest x-ray and CAD versus no screening
Time Frame: One year after scan
All cause mortality rate
One year after scan
Length of time between randomization and the incidence of symptomatic advanced lung cancer for screened subjects versus controls
Time Frame: One year after scan
Time between randomization and symptom
One year after scan
Does lung cancer screening with chest x-rays and computer aided detection (CAD) reduce the incidence of symptomatic advanced lung cancer in a high risk population
Time Frame: One year after scan
Cancer detection rate between chest x-ray and CAD
One year after scan
The quality of life between screening with chest x-ray and CAD versus no screening.
Time Frame: One year after scan
Quality of life between the chest x-ray group and the CAD group
One year after scan

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Micheal Phillips, M.D., The Cleveland Clinic
  • Principal Investigator: Moulay Meziane, MD, Chair of Thoracic Imaging

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

November 10, 2008

First Submitted That Met QC Criteria

August 9, 2012

First Posted (Estimate)

August 13, 2012

Study Record Updates

Last Update Posted (Actual)

May 18, 2017

Last Update Submitted That Met QC Criteria

May 17, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 07-455
  • State of Ohio grant (Other Grant/Funding Number: 06-055)
  • 06-055 (Other Grant/Funding Number: State of Ohio)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on chest x-ray with or without CAD, lose dose CT scan

3
Subscribe